You just read:

BioLineRx Receives Orphan Drug Designation From the FDA for its Lead Therapeutic Candidate BL-8040 for the Treatment of Pancreatic Cancer

News provided by

BioLineRx Ltd

Feb 04, 2019, 07:00 ET